Skip to content
Home/Companies/Biotech/Aprea

Aprea

Biotech·Sweden·Exited 2019·Held 3yr
Entry
2016
Hold
3yr
Exit
2019

Who owns Aprea?

Aprea is a Swedish Biotech company, formerly owned by HealthCap, exited in 2019 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VII · 2016 · VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2019

More from HealthCap VII

Other portfolio companies in the same fund.

Mahzi Therapeutics
Active
BiotechUS· 2020
Priothera Ltd.
Active
BiotechIreland· 2020
SynOx Therapeutics Ltd
Active
BiotechIreland· 2020
Carisma Therapeutics
Exited 2023
BiotechUS· 2018
to Sesen Bio, Inc.
InCarda Therapeutics Inc.
Active
BiotechUS· 2018
Modus Therapeutics
Modus Therapeutics
Active
BiotechSweden· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Aprea?

Aprea was formerly owned by HealthCap, exited in 2019. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue